Harbourvest Partners LLC Kaleido Biosciences, Inc. Transaction History

Harbourvest Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $91,691 - $3.12 Million	-1,833,832 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.77 - $11.33 $497,345 - $976,589	-86,195 Reduced 4.49%	1,833,832 $16.7 Million
Q3 2020 Nov 12, 2020	BUY	$5.09 - $11.07 $438,732 - $954,178	86,195 Added 4.7%	1,920,027 $23.4 Million
Q2 2020 Aug 13, 2020	BUY	$4.62 - $8.01 $3.08 Million - $5.34 Million	666,666 Added 57.12%	1,833,832 $13.6 Million
Q1 2019 May 13, 2019	BUY	$12.71 - $15.0 $14.8 Million - $17.5 Million	1,167,166 New	1,167,166 $16.9 Million

2.3K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Harbourvest Partners LLC with notifications on news.